TechnoMark News

The growing prevalence of various cancers resulted in an increased adoption of radiopharmaceuticals in diagnosis and treatment of several cancers in developed economies. For instance, according to globocan cancer statistics, There were 14.1 million new cancer cases, 8.2 million cancer deaths and 32.6 million people living with cancer (within 5 years of diagnosis) in 2012 worldwide. Moreover, advances in technology such as introduction of PET radiotracers and targeted radioimmunotherapies expected to drive the overall market revenue growth over the forecast period. Major Key Players of the Radiopharmaceuticals-Nuclear Medicine Market are: Advanced Accelerator Applications S.A. (France), Bayer AG (Germany), Bracco Imaging S.p.A (Italy), Cardinal Health, Inc. (U.S.), Eli Lilly and Co. (U.S.), GE Healthcare (U.S.), BA Molecular Imaging (Belgium), Jubilant Life Sciences Ltd (India), Lantheus Medical Imaging, Inc. (U.S.), Mallinckrodt plc (Ireland), Navidea Biopharmaceutical (U.S.), Nordion,...

Global Nuclear Medicine Market Size study report with COVID-19 effect is considered to be an extremely knowledgeable and in-depth evaluation of the present industrial conditions along with the overall size of the Nuclear Medicine industry, estimated from 2020 to 2025. The research report also provides a detailed overview of leading industry initiatives, potential market share of Nuclear Medicine, and business-oriented planning, etc. The study discusses favorable factors related to current industrial conditions, levels of growth of the Nuclear Medicine industry, demands, differentiable business-oriented approaches used by the manufacturers of the Nuclear Medicine industry in brief about distinct tactics and futuristic prospects. Major Players Covered in this Report are: Bracco Imaging S.P.A, Cardinal Health, Nordion, Inc., Philips Healthcare, Digirad, Siemens Healthcare, Mallinckrodt PLC, GE Healthcare, Ashby Gorman Baker Ltd, Bayer Healthcare, Lantheus Medical Imaging, Advanced Acceler...